Inflammatory and autoimmune diseases such as MS are associated with constitutive activation of NF-κB which leads to excessive expression of the effector molecules whose transcription relies on the NF-κB pathway (Li and Verma, 2002; Yamamoto and Gaynor, 2004). Here, NFKB1 is linked to autoimmune disease.